Prospective, Randomised, Comparative Study Comparing Efficacy of Continuous Apomorphine Infusion Versus Usual Dopaminergic Per os Treatment on Cognitive and Neuropsychological Functions in Parkinson's Disease: a Clinical and PET-scan Study.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Apomorphine (Primary) ; Dopamine receptor agonists
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms APO-TEP
- 30 Nov 2012 Planned end date changed from 1 Aug 2011 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 07 Jan 2010 New trial record